Cancer
Malignant Pancreatic Neoplasm
CI-CAN-00001159Explore in graph →
Top-level904 active trials8 approved drugs63 evidence items
- NCIt
- C9005
- ICD-10
- C25
- DOID
- 1793
- Other
- 1 more code
Loading cancer entity…
Loading cancer entity…
Cancer
CI-CAN-00001159Explore in graph →
Clinical trials
3,630 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (516)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT03884179 | Diagnosis of PCL With EUS-FNA and Cross-sectional Imaging - A Report of Accuracy | unknown | — | 58 | Sahlgrenska University HospitalOTHER | 0 | Mar 21, 2019 | clinicaltrials |
| NCT03468244 | Clinical Study of Personalized mRNA Vaccine Encoding Neoantigen in Patients With Advanced Digestive System Neoplasms | unknown | N/A | 24 | Changhai HospitalOTHER | 1 | Feb 26, 2019 | clinicaltrials |
| NCT03821025 | Self-expandable Metal Stents Versus Multiple Plastic Stents for Palliation of Biliary Obstruction | unknown | N/A | 150 | University of Cape TownOTHER | 1 | Feb 20, 2019 | clinicaltrials |
| NCT02898649 | Safety and Efficacy of Irreversible Electroporation for Locally Advanced Pancreatic Cancer | unknown | N/A | 100 | Yonsei UniversityOTHER | 1 | Feb 15, 2019 | clinicaltrials |
| NCT02433626 | Study of COTI-2 as Monotherapy or Combination Therapy for the Treatment of Malignancies(COTI2-101) | unknown | Phase 1 | 51 | Critical Outcome Technologies Inc.INDUSTRY | 1 | Feb 1, 2019 | clinicaltrials |
| NCT03821909 | Acquisition of Portal Venous CTCs and Exosomes From Patients With Pancreatic Cancer by EUS(CTCs) | unknown | — | 30 | Ying LvOTHER | 1 | Jan 31, 2019 | clinicaltrials |
| NCT03825328 | A Trial of NS/GEMOX Chemotherapy in Patients With Untreated Pancreatic Cancer ( HZ-NS/GEMOX-PC ) | unknown | Phase 2 | 30 | Yanqiao ZhangOTHER | 0 | Jan 31, 2019 | clinicaltrials |
| NCT03820921 | Evaluation of MMR Status and PD-L1 Expression Using Specimens Obtained by EUS-FNB in Patients With Pancreatic Cancer(SUCCESS) | unknown | — | 30 | Ponderas Academic HospitalOTHER | 0 | Jan 29, 2019 | clinicaltrials |
| NCT02659852 | A Study for Efficacy of Side-by-side Compared to Stent-in-stent Technique in the Endoscopic Management of Malignant Hilar Biliary Obstruction | unknown | N/A | 70 | Yonsei UniversityOTHER | 1 | Jan 28, 2019 | clinicaltrials |
| NCT03524677 | Mutation of K-RAS, CDKN2A, SMAD4 and TP53 in Pancreatic Cancer: Role of Liquid Biopsy in Preoperative Diagnosis | unknown | — | 50 | University of Roma La SapienzaOTHER | 2 | Jan 25, 2019 | clinicaltrials |
| NCT03815461 | Nab-paclitaxel Combined With S-1 as Induction Therapy for Locally Advanced Pancreatic Cancer | unknown | Phase 2 | 60 | Chinese Academy of Medical SciencesOTHER | 1 | Jan 25, 2019 | clinicaltrials |
| NCT03606148 | SurePathTM Liquid-based Cytology and Conventional Smear Cytology in Pancreatic Lesions | unknown | — | 170 | Seoul National University HospitalOTHER | 1 | Jan 23, 2019 | clinicaltrials |
| NCT03058926 | Coordinating and Data Management Center for the Consortium for the Study of Chronic Pancreatitis, Diabetes, and Pancreatic Cancer | unknown | — | 25,000 | M.D. Anderson Cancer CenterOTHER | 1 | Jan 14, 2019 | clinicaltrials |
| NCT03634501 | Clinical Study on Anti-tumor Effect Induced by Activated Primary Natural Killer（NK）Cells | unknown | Phase 1 / Phase 2 | 200 | Xuanwu Hospital, BeijingOTHER | 1 | Jan 11, 2019 | clinicaltrials |
| NCT03673423 | Evaluation of the Interobserver Agreement on the Resectability Status of Patients With a Pancreatic Cancer(OBTCPAN) | unknown | — | 138 | Ospedale San RaffaeleOTHER | 1 | Dec 13, 2018 | clinicaltrials |
| NCT03768687 | A Real-world Study of Albumin-bound Paclitaxel in the Treatment of Pancreatic Cancer | unknown | — | 300 | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical SchoolOTHER | 1 | Dec 10, 2018 | clinicaltrials |
| NCT03763214 | PTFE Stents for Treatment of Malignant Biliary Strictures | unknown | N/A | 64 | Johannes VermehrenOTHER | 1 | Dec 4, 2018 | clinicaltrials |
| NCT03210948 | Conventional Versus Elastography Targeted Endoscopic Ultrasound Fine Needle Aspiration of Solid Pancreatic Lesions | unknown | N/A | 142 | Ospedali Riuniti di FoggiaOTHER | 1 | Nov 27, 2018 | clinicaltrials |
| NCT03749005 | Impact of Three-dimensional Visualization on Operation Strategy and Complications for Pancreatic Cancer | unknown | — | 100 | Zhujiang HospitalOTHER | 1 | Nov 21, 2018 | clinicaltrials |
| NCT03517332 | Circulating Tumor DNA Exposure in Peripheral Blood | unknown | — | 10,000 | Quantgene Inc.INDUSTRY | 2 | Nov 20, 2018 | clinicaltrials |
| NCT03400072 | Adapted Physical Activity in Patients With Resected Pancreatic Cancer (APACaPOp PRODIGE-56 Study): a National Multicenter Randomized Controlled Phase II Trial(APACaPOp) | unknown | N/A | 252 | Centre Hospitalier Universitaire de BesanconOTHER | 1 | Nov 19, 2018 | clinicaltrials |
| NCT03398291 | Simultaneous Resection of Pancreatic Cancer and Liver Oligometastasis After Induction Chemotherapy | unknown | Phase 3 | 300 | Fudan UniversityOTHER | 1 | Oct 9, 2018 | clinicaltrials |
| NCT03690323 | Pancreatic Locally Advanced Irresectable Cancer Ablation(PELICAN) | unknown | N/A | 228 | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)OTHER | 1 | Oct 1, 2018 | clinicaltrials |
| NCT03687853 | Application of Intrahepatic Arterial Infusion Chemotherapy for Patients With High Risk of Liver Metastases After Pancreatic Cancer Surgery | unknown | N/A | 80 | Peking University Third HospitalOTHER | 1 | Sep 27, 2018 | clinicaltrials |
| NCT03685370 | PERiX: Comparison of Efficacy Between Placement of Epidural Catheters X-ray Guided and LOS Technique(PERiX) | unknown | N/A | 154 | Azienda Ospedaliera Universitaria Integrata VeronaOTHER | 1 | Sep 26, 2018 | clinicaltrials |
| NCT03679910 | Evaluation of CEMIP in Pancreatic Cancer | unknown | — | 90 | Assiut UniversityOTHER | 1 | Sep 21, 2018 | clinicaltrials |
| NCT03662035 | Apatinib Combined With S-1 in the Second-line Treatment of Advanced Pancreatic Cancer(ASPC) | unknown | Phase 2 | 30 | Changzhou No.2 People's HospitalOTHER | 0 | Sep 19, 2018 | clinicaltrials |
| NCT03668418 | Xenotransplantation of Primary Cancer Samples in Zebrafish Embryos(xenoZ) | unknown | — | 120 | University of PisaOTHER | 1 | Sep 12, 2018 | clinicaltrials |
| NCT03642093 | HOPE - A Study to Evaluate the Effect of a Prehabilitation Program on GI Cancer Patients Planning to Undergo Surgery(HOPE) | unknown | Phase 4 | 60 | Siobhan TrotterOTHER | 1 | Sep 11, 2018 | clinicaltrials |
| NCT03662412 | Study of Sirolimus in Patients With Advanced Pancreatic Cancer | unknown | Phase 1 / Phase 2 | 36 | Second Affiliated Hospital, Zhejiang University, School of MedicineOTHER | 1 | Sep 7, 2018 | clinicaltrials |
| NCT03659292 | Effects of Epidural Block on the Prognosis in Patients With Pancreatic Cancer Undergoing Distal Pancreatectomy | unknown | N/A | 540 | Fudan UniversityOTHER | 1 | Sep 6, 2018 | clinicaltrials |
| NCT03228095 | Volatiles in Breath and Headspace Analysis - Diagnostic Markers(Volatolome) | unknown | — | 3,000 | University of LatviaOTHER | 1 | Aug 21, 2018 | clinicaltrials |
| NCT03636308 | Nab-paclitaxel Plus S-1(AS) Versus Nab-paclitaxel Plus Gemcitabine(AG) in Patients With Advanced Pancreatic Cancer(ASAGPAC) | unknown | Phase 2 | 40 | Peking UniversityOTHER | 1 | Aug 17, 2018 | clinicaltrials |
| NCT02975141 | Afatinib and Gemcitabine/Nab-paclitaxel in Metastatic Pancreatic Cancer(AFFECT) | unknown | Phase 1 | 12 | PD Dr. med. Volker HeinemannOTHER | 1 | Aug 13, 2018 | clinicaltrials |
| NCT03607643 | A Study of the Efficacy of Cannabidiol in Patients With Multiple Myeloma, Glioblastoma Multiforme, and GI Malignancies | unknown | Phase 1 / Phase 2 | 160 | Leaf Vertical Inc.INDUSTRY | 1 | Jul 31, 2018 | clinicaltrials |
| NCT03570502 | Incidence of POPF in the Resection of the Left Pancreas With RFAT(RFATPancreas) | unknown | — | 38 | Hospital del MarOTHER | 1 | Jun 27, 2018 | clinicaltrials |
| NCT03460925 | Improving REsectability in Pancreatic NEoplasms (IRENE)(IRENE) | unknown | N/A | 14 | IRCCS Azienda Ospedaliero-Universitaria di BolognaOTHER | 1 | May 30, 2018 | clinicaltrials |
| NCT03513198 | Perfusion Assessment With Contrast-Enhanced EUS in Locally Advanced and Metastatic Pancreatic Cancer(PEACE) | unknown | — | 200 | University of Medicine and Pharmacy CraiovaOTHER | 0 | May 1, 2018 | clinicaltrials |
| NCT03502343 | Efficacy and Safety of Modified Nab-Paclitaxel Plus Gemcitabine Chemotherapy for Metastatic Pancreatic Cancer | unknown | Phase 2 | 52 | Yonsei UniversityOTHER | 1 | Apr 18, 2018 | clinicaltrials |
| NCT03497819 | Autologous CARTmeso/19 Against Pancreatic Cancer | unknown | Early Phase 1 | 10 | First Affiliated Hospital of Wenzhou Medical UniversityOTHER | 1 | Apr 13, 2018 | clinicaltrials |
| NCT03366038 | Shark Mouth Modified Pancreaticojejunostomy(SMMP) | unknown | — | 120 | Peking University Third HospitalOTHER | 1 | Apr 5, 2018 | clinicaltrials |
| NCT03076372 | A Study Evaluating MM-310 in Patients With Solid Tumors | unknown | Phase 1 | 34 | Merrimack PharmaceuticalsINDUSTRY | 1 | Feb 27, 2018 | clinicaltrials |
| NCT03443921 | Divestment for Artery-involved Pancreatic Cancer | unknown | N/A | 122 | The First Affiliated Hospital with Nanjing Medical UniversityOTHER | 1 | Feb 23, 2018 | clinicaltrials |
| NCT03435770 | Evaluation of Safety and Feasibility of EUS-guided RFA for Solid Pancreatic Neoplasms | unknown | N/A | 10 | Singapore General HospitalOTHER | 1 | Feb 20, 2018 | clinicaltrials |
| NCT03435289 | A Study of CPI-613 With Gemcitabine and Nab-paclitaxel for Patients With Advanced or Metastatic Pancreatic Cancer | unknown | Phase 1 | 24 | Atlantic Health SystemOTHER | 1 | Feb 19, 2018 | clinicaltrials |
| NCT03417843 | Safety and Efficacy of an Ablation Catheter for the Treatment of Pancreatic Premalignant Cyctic Lesions.(yes) | unknown | N/A | 20 | HaEmek Medical Center, IsraelOTHER | 0 | Feb 13, 2018 | clinicaltrials |
| NCT03401827 | The Effect of Gemcitabine Plus Nab-paclitaxel as Secondary Chemotherapy in Advanced Pancreatic Cancer | unknown | Phase 4 | 40 | Seoul National University HospitalOTHER | 1 | Feb 12, 2018 | clinicaltrials |
| NCT03214991 | Circulating Tumor DNA as a Prognostic Marker in Patients With Pancreatic Cancer | unknown | — | 100 | Ji Kon RyuOTHER | 1 | Feb 5, 2018 | clinicaltrials |
| NCT02978547 | The Effects of Neoadjuvant Metformin on Tumour Cell Proliferation and Tumour Progression in Pancreatic Ductal Adenocarcinoma(Metformin 001) | unknown | Phase 2 | 20 | British Columbia Cancer AgencyOTHER | 1 | Jan 18, 2018 | clinicaltrials |
| NCT02862015 | Multicenter RCT of the Clinical Effectiveness of Oncothermia With Chemotherapy in Metastatic Pancreatic Cancer Patients(Oncothermia) | unknown | Phase 2 | 100 | Seoul National University HospitalOTHER | 1 | Oct 31, 2017 | clinicaltrials |
Data updated 23 days agoSource updated Mar 21, 2019source: clinicaltrials